Therapeutic neovascularization: Contributions from bioengineering

Tissue Engineering

Volumn 11, Issue 3-4, 2005, Pages 567-584

  Brey, Eric M ^a,b,c   Uriel, Shiri ^a   Greisler, Howard P ^b,c   Patrick Jr , Charles W ^d   McIntire, Larry V ^e  

^a Illinois Institute of Technology   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c HINES VA HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; PATHOLOGY; SURGERY;

ANGIOGENESIS; CLINICAL PROBLEMS; NEOVASCULARIZATION; THERAPEUTIC STIMULATION;

BIOMEDICAL ENGINEERING;

ANGIOPOIETIN 1; ANGIOPOIETIN 2; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GELATIN; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN BCL 2; SCATTER FACTOR; VASCULOTROPIN;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; BIOENGINEERING; CAPILLARY DENSITY; CAPILLARY FLOW; COMPUTER MODEL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE THERAPY; HEART MUSCLE ISCHEMIA; LIMB ISCHEMIA; MATHEMATICAL MODEL; MICROENVIRONMENT; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; STOICHIOMETRY;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOMEDICAL ENGINEERING; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MODELS, CARDIOVASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 18244405768     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.567     Document Type: Review

References (142)

1. Jain, R.K. Molecular regulation of vessel maturation. Nat Med. 9, 685, 2003.
2. Azrin, M. Angiogenesis, protein and gene delivery. Br. Med. Bull. 59, 211, 2001.
3. Post, M.J., Laham, R., Sellke, F.W., and Simons, M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc. Res. 49, 522, 2001.
4. Sellke, F.W., and Ruel, M. Vascular growth factors and angiogenesis in cardiac surgery. Ann. Thorac. Surg. 75, S685, 2003.
5. Simons, M., Bonow, R.O., Chronos, N.A., Cohen, D.J., Giordano, F.J., Hammond, K., Laham, R.J., Li, W., Pike, M., Sellke, F.W., Stegmann, T.J., Udelson, J.E., and Rosengart, T.K. Clinical trials in coronary angiogenesis: Issues, problems, consensus an expert panel summary. Circulation 102, 1, 2000.
6. Epstein, S.E., Kornowski, R., Fuchs, S., and Dvorak, H.F. Angiogenesis therapy: Amidst the hype, the neglected potential for serious side effects. Circulation 104, 115, 2001.
7. Chen, R.R., and Mooney, D.J. Polymeric growth factor delivery strategies for tissue engineering. Pharm. Res. 20, 1103, 2003.
8. Zisch, A.H., Lutolf, M.P., and Hubbell, J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc. Pathol. 12, 295, 2003.
9. Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 936, 2003.
10. Peirce, S.M., and Skalak, T.C. Microvascular remodeling: A complex continuum spanning angiogenesis to arterio-genesis. Microcirculation 10, 99, 2003.
11. Van Royen, N., Piek, J.J., Buschmann, I., Hoefer, I., Voskuil, M., and Schaper, W. Stimulation of arteriogenesis: A new concept for the treatment of arterial occlusive disease. Cardiovasc. Res. 49, 543, 2001.
12. Raffi, S, and Lyden, D. Therapeutic stem cell and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9, 702, 2003.
13. Soker, S., Machado, M., and Atala, A. Systems for therapeutic angiogenesis in tissue engineering. World J. Urol. 18, 10, 2000.
14. Yla-Herrtuala, S., and Alitalo, K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9, 694, 2003.
15. Chaplain, M.A. Mathematical modeling of angiogenesis. J. Neurooncol. 50, 37, 2000.
16. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. Angiogenesis assays: A critical overview. Clin. Chem. 49, 32, 2003.
17. Rebar, E.J. Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease. Expert Opin. Investig. Drugs 13, 829, 2004.
18. Risau, W. Mechanisms of angiogenesis. Nature 386, 671, 1997.
19. Kurz, H., Burri, P.H., and Djonov, V.G. Angiogenesis and vascular remodeling by intussusception: From form to function. News Physiol. Sci. 18, 65, 2003.
20. Patan, S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation: Growth and remodeling. J. Neurooncol. 50, 1, 2000.
21. Augustin, H. Tubes, branches, and pillars: The many ways of forming a new vasculature. Circ. Res. 89, 645, 2001.
22. Hirschi, K., and Goddell, M. Common origins of blood and blood vessels in adults. Differentiation 68, 186, 2001.
23. Scholz, D., Cai W.J., and Schaper, W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 2, 247, 2001.
24. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
25. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. Selective ablation of immature blood vessels in established tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159, 1999.
26. Cleland, J.L., Duenas, E.T., Park, A., Daughterly, A., Kahn, J., Kowalski, J., and Cuthbertson, A. Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control. Release 72, 13, 2001.
27. Murphy, W.L., Peters, M.C., Kohn, D.H., and Mooney, D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21, 2521, 2000.
28. Shea, L.D., Smiley, E., Bonadio, J., and Mooney, D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551, 1999.
29. King, T.W., and Patrick, C.W., Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J. Biomed. Mater. Res. 51, 383, 2000.
30. Elcin, Y.M., Dixit, V., and Gitnick, G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: Implications for tissue engineering and wound healing. Artif. Organs 25, 558, 2001.
31. Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Msuoka, K., Saito, Y., Yura, H., Matsui, T., Hattori, H., Kikuchi, M., and Kurita, A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res. 64A, 551, 2003.
32. Tabata, Y., and Ikada, Y. Protein release from gelatin matrices. Adv. Drug Deliv. Rev. 4, 287, 1998.
33. Fujioka, K., Maeda, M., Hojo, T., and Sano, A. Protein release from collagen matrices. Adv. Drug Deliv. Rev. 31, 247, 1998.
34. Greisler, H.P., Cziperle, D.J., Kim, D.U., Garfield, J.D., Petsikas, D., Murchan, P.M., Applegren, E.O., Drohan, W., and Burgess, W.H. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor 1 pretreatment. Surgery 112, 244, 1992.
35. Baier Leach, J., Bivens, K.A., Patrick, C.W., Jr., and Schmidt, C.E. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol. Bioeng. 82, 578, 2003.
36. Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., McDonagh, J., and Dvorak, A.M. Fibrin containing gels induce angiogenesis implications for tumor stroma generation and wound healing. Lab. Invest. 57, 673, 1987.
37. Hodde, J.P., Record, R.D., Liang, H.A., and Badylak, S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 8, 11, 2001.
38. Tabata, Y., and Ikada, Y. Vacularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20, 2169, 1999.
39. Schense, J.S., and Hubbell, J.A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10, 75, 1999.
40. Zisch, A.M., Schenk, U., Schense, J.C., Sakiyama-Elbert, S.E., and Hubbell, J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Control. Release 72, 101, 2001.
41. 121 from fibrin implants induces local and controlled blood vessel growth. Circ. Res. 94, 1124, 2004.
42. Zisch, A.H., Zeisberger, S.M., Ehrbar, M., Djonov, V., Weber, C.C., Ziemiecki, A., Pasquale, E.B., and Hubbell, J.A. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: Study of angiogenic signaling by ephrin-B2. Biomaterials 25, 3245, 2004.
43. Seliktar, D., Zisch, A.H., Lutolf, M.P., Wrana, J.L., and Hubbell, J.A. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J. Biomed. Mater. Res. 68A, 704, 2004.
44. Ingber, D.E. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res. 91, 877, 2002.
45. Korff, T., and Augustin, H.G. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell Sci. 112, 3249, 1999.
46. Lee, K.Y., Peters, M.C., Anderson, K.W., and Mooney, D.J. Controlled growth factor release from synthetic extracellular matrics. Nature 408, 998, 2000.
47. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, DJ. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029, 2001.
48. Hirschi, K.K., Rohovsky, S.A., Beck, L.H., Smith, S.R., and D'Amore, P.S. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84, 298, 1999.
49. 164 and Ang-1. Am. J. Physiol. Heart Circ. Pysiol. 286, H918, 2004a.
50. Lubiatowski, P., Gurunluoglu, R., Goldman, C.K., Skugor, B., Carnevale, K., and Siemionow, M. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast. Reconstr. Surg. 111, 1380, 2003.
51. Roethy, W., Fiehn, E., Suehiro, K., Gu, A., Yi, G.H., Shmizu, J., Wang, J., Zhang, G., Ranieri, J., Akella, R., Funk, S.E., Sage, E.H., Benedict, J., and Burkhoff, D. A growth factor mixture that significantly enhances angiogenesis in vivo. J. Pharmacol. Exp. Ther. 299, 494, 2001.
52. Kiefer, F.N., Neysari, S., Humar, R., Li, W., Munk, V.C., and Battegay, E.J. Hypertension and angiogenesis. Curr. Pharm. Des. 9, 1733, 2003.
53. Ruel, M., Wu, G.F., Khan, T.A., Voisine, P., Bianchi, C., Li, J., Laham, R.J., and Sellke, F.W. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a swine endothelial dysfunction model. Circulation 108(Suppl. 1), II335, 2003.
54. Xue, L., Shireman, P.K., Hampton, B., Burgess, W.H., and Greisler, H.P. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells. J. Surg. Res. 92, 255, 2000.
55. Shireman, P.K., Xue, L., Maddox, E., Burgess, W.H., and Greisler, H.P. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells. J. Surg. Res. 92, 255, 2000.
56. Xue, L., Tassiopoulos, A.K., Woloson, S.K., Stanton, D.L., Jr., Ms, C.S., Hampton, B., Burgess, W.H., and Greisler, H.P. Construction and characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering. J. Vasc. Surg. 33, 554, 2001.
57. Tassiopoulos, A.K., and Greisler, H.P. Angiogenic mechanisms of endothelialization of cardiovascular implants: A review of recent investigative strategies. J. Biomater. Sci. Polym. Ed. 11, 1275, 2000.
58. Rebar, E.J., Huang, Y., Hickey, R., Nath, A.K., Meoli, D., Nath, S., Chen, B., Xu, L., Liang, Y., Jamieson, A.C., Zhang, L., Spratt, S.K., Case, C.C., Wolffe, A., and Giordano, F.J. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat. Med. 8, 1427, 2002.
59. Vincent, K.A., Shyu, K.G., Luo, Y., Magner, M., Tio, R.A., Jiang, C., Goldberg, M.A., Akita, G.Y., Gregory, R.J., and Isner, J.M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor. Circulation 102, 2255, 2000.
60. Wittrup, K.D. Protein engineering by cell-surface display. Curr. Opin. Biotechnol. 12, 395, 2001.
61. Grieb, T.A., and Burgess, W.H. The mitogenic activity of fibroblast growth factor-1 correlates with its internalization and limited proteolytic processing. J. Cell Physiol. 184, 171, 2000.
62. Holder, W.D., Gruber, H.E., Roland, W.D., Moore, A.L., Culberson, C.R., Burg, K.J.L., and Mooney, D.J. Increased vascularization and heterogeneity of vascular structures occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat. Tissue Eng. 3, 149, 1997.
63. Nor, J.E., Christensen, J., Mooney, D.J., and Polverini, P.J. VEGF-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of bcl-2 expression. Am. J. Pathol. 154, 375, 1999.
64. Nor, J.E., Peters, M., Christensen, J.B., Sutorik, M.M., Linn, S., Khan, M.K., Addison, C.L., Mooney, D.J., and Polverini, P.J. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab. Invest. 81, 453, 2001.
65. Schechner, J.S., Nath, A.K., Zheng, L., Kluger, M.S., Hughes, C.C.W., Sierra-Honigmann, M.R., Lorber, M.I., Tellides, G., Kashgarian, M., Bothwell, A.L.M., and Pober, J.S. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl. Acad. Sci. U.S.A. 97, 9191, 2000.
66. Skovseth, D.K., Yamanaka, T., Brandtzaeg, P., Butcher, E.C., and Haraldsen, G. Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am. J. Pathol. 160, 1629, 2002.
67. Park, S., Tapper, O., Galiano, R., Capla, J., Baharestani, S., Kleinman, M.E., Pelo, C., Levine, J.P., and Gurtner, G.C. Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast. Reconstr. Surg. 113, 284, 2004.
68. Levenberg, S., Golub, J.S., Amit, M., Iskovitz-Eldor, J., and Langer, R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99, 4391, 2002.
69. Marchetti, S., Gimond, C., Lijin, K., Bourcier, C., Alitalo, K., Pouyssegur, J., and Pages, G. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J. Cell Sci. 115, 2075, 2002.
70. Borges, J., Mueller, M.C., Padron, N.T., Tegtmeier, F., Lang, E.M., and Stark, G.B. Engineered adipose tissue supplied by functional microvessels. Tissue Eng. 9, 1263, 2003.
71. Nor, J.E., Christensen, J., Liu, J., Peters, M., Mooney, D.J., Strieter, R.M., and Polverini, P.J. Up-regulation of bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res. 61, 2183, 2001.
72. Ikeda, Y., Fukuda, N., Wada, M., Matsumoto, T., Satomi, A., Yokoyama, S., Saito, S., Matsumoto, K., Kanmatsuse, K., and Mugishima, H. Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens. Res. 27, 199, 2004.
73. Sieminski, A.L., Padera, R.F., Blunk, T., and Gooch, K.J. Systemic delivery of human growth hormone using genetically modified tissue-engineered microvascular networks: Prolonged delivery and endothelial cell survival with inclusion of nonendothelial cells. Tissue Eng. 8, 1057, 2002.
74. Black, A.F., Berthod, F., L'Heureux, N., Germain, L., and Auger, F.A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12, 1331, 1998.
75. Supp, D.M., Wilson-Landy, K., and Boyce, S.T. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J. 16, 797, 2002.
76. Park, H.J., Yoo, J.J., Kershen, R.T., Moreland, R.B, and Atala, A. Reconstruction of human corporal smooth muscle and endothelial cells in vivo. J. Urol. 162, 1106, 1999.
77. Koike, N., Fukumura, D., Gralla, O., Au, P., Schechner, J.S., and Jain, R.K. Tissue engineering: Creation of long lasting blood vessels. Nature 428, 138, 2004.
78. Kushida, A., Yamato, M., Konno, C., Kikuchi, A., Sakurai, Y., and Okano, T. Decrease in culture temperature releases monolayer endothelial cells together with deposited fibronectin matrix from temperature-responsive culture surfaces. J. Biomed. Mater. Res. 45, 355, 1999.
79. Harimoto, M., Yamato, M., Hirose, M., Takahasi, C., Isoi, Y., Kikuchi, A., and Okano, T. Novel approach for achieving double-layered cell sheets co-culture: Overlaying endothelial cells sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J. Biomed. Mater. Res. 62, 464, 2002.
80. Rinsch, C., Quinodoz, P., Pittet, B., Alizadeh, N., Baetens, D., Montandon, D., Aebischer, P., and Pepper, M.S. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 8, 523, 2001.
81. Kaihara, S., Borenstein, J., Koka, R., Lalan, S., Ochoa, E.R., Ravens, M., Pien, H., Cunningham, B., and Vacanti, J.P. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 6, 105, 2000.
82. Therriault, D., White, S.R., and Lewis, J.A. Chaotic mixing in three-dimensional microvascular networks fabricated by direct-write assembly. Nat. Mater. 2, 265, 2003.
83. Dike, L.E., Chen, C.S., Mrksich, M., Tien, J., Whitesides, G.M., and Ingber, D.E. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev. Biol. Anim. 35, 44, 1999.
84. Wang, Y.C., and Ho, C.C. Micropatterning of proteins and mammalian cells on biomaterials. FASEB J. 18, 525, 2004.
85. Moldovan, N.I., and Ferrari, M. Prospects for microtechnology and nanotechnology in bioengineering of replacement vessels. Arch. Pathol. Lab. Med. 126, 320, 2002.
86. Sanders, J.E., Malcolm, S.G., Bale, S.D., Wang, Y.N., and Lamont, S.E. Prevascularization of a biomaterial using a chorioallontoic membrane. Microvasc. Res. 64, 174, 2002.
87. Sanders, J.E., Wang, Y.N., Malcolm, S.G., and Lamont, S. Biomaterial mesh seeded with vascular remnants from a quail embryo has a significant and fast vascular templating effect on host implant tissue. Tissue Eng. 9, 1271, 2003.
88. Moldovan, N.I. Role of monocytes and macrophages in adult angiogenesis: A light at the tunnel's end. J. Hematother. Stem Cell Res. 11, 179, 2002.
89. Daly, C.D., Campbell, G.R., Walker, P.J., and Campbell, J.H. In vivo engineering of blood vessels. Front Biosci. 9, 1915, 2004.
90. Wake, M.C., Patrick, C.W., Jr., and Mikos, A.G. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant. 3, 339, 1994.
91. Orgill, D.P., Butler, C.W., Regan, J.F., Barlow, M.S., Yannas, I.V., and Compton, C.C. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves the take of cultured epithelial autografts. Plast. Reconstr. Surg. 102, 423, 1998.
92. Cassell, O.C., Morrison, W.A., Messina, A., Pennington, A.J., Thompson, E.W., Stevens, G.W., Perera, J.M., Kleinmam, H.K., Hurley, J.V., Romeo, R., and Knight, K. The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann. N.Y. Acad. Sci. 944, 429, 2001.
93. Cheng, M.H., Brey, E.M., Allori, A., Satterfield, W.C., Chang, D.W., Patrick, C.W., Jr., and Miller, M.J. Ovine model for engineering bone segments. Tissue Eng. 11, 214, 2005.
94. Miller, M.J., Goldberg, D., Yasko, A.W., Lemon, J.C., Satterfield, W., Wake, M.C., and Mikos, A.G. Guided bone growth in sheep: A model for tissue-engineered bone flaps. Tissue Eng. 2, 51, 1996.
95. Thomson, R.C., Mikos, A.G., Beahm, E., Lemon, J.C., Satterfield, W.C., Aufdemorte, T.B., and Miller, M.J. Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials 20, 2007, 1999.
96. Cheng, M.H., Brey, E.M., Wei, F.C., and Chen, H.C. Application of tissue engineering strategies to the prefabrication of an osseous free flap: A clinical case. Tissue Eng. 8, 1221, 2002.
97. Badylak, S.F., Grompe, M., Caplan, A.I., Greisler, H.P., Guldberg, R.E., and Taylor, D.A. In vivo remodeling. Ann. N.Y. Acad. Sci. 961, 319, 2002.
98. Kondoh, K., Koyama, H., Miyata, T., Takato, T., Hamada, H., and Shigematsu, H. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc. Res. 61, 132, 2004.
99. Ito, W.D., Arras, M., Winkler, B., Scholz, D., Schaper, J., and Schaper, W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80, 829, 1997.
100. Buschmann, I.R., Hoefer, I.E., van Royen, N., Katzer, E., Braun-Dulleaus, R., Heil, M., Kostin, S., Bode, C., and Schaper, W. GM-CSF: A strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159, 343, 2001.
101. Hershey, J.C., Corcoran, H.A., Baskin, E.P., Gilberto, D.B., Mao, X., Thomas, K.A., and Cook, J.J., Enhanced hind-limb collaterialization induced by acidic fibroblast growth factor is dependent on femoral artery extraction. Cardiovasc. Res. 59, 997, 2003.
102. Srivastava, S., Terjung, R.L., and Yang, H.T. Basic fibroblast growth factor increases collateral blood flow in sponateously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 285, H1190, 2003.
103. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., Leboulch, P., and Cao, Y. Angiogenic synergism, vascular stability and improvement of hindlimb ischemia by a combination of PDGF-BB and FGF-2. Nat.-Med. 9, 604, 2003.
104. Siddiqui, A.J., Blomberg, P., Wardell, E., Hellgren, I., Eskandarpour, M., Islam, K.B., and Sylven, C. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem. Biophys. Res. Commun. 310, 1002, 2003.
105. Herold, J., Pipp, F., Fernadndez, B., Xing, Z., Heil, M., Tillmanns, H., and Braun-Dullaeus, R.C. Transplantation of monocytes: A novel strategy for in vivo augmentation of collateral vessel growth. Hum. Gene Ther. 15, 1, 2004.
106. McIntire, L.V. Vascular assembly in engineered and natural tissues. Ann. N.Y. Acad. Sci. 961, 246, 2002.
107. Krogh, A. The Anatomy and Physiology of the Capillary. New Haven, CT: Yale University Press, 1922.
108. Zweifach, B.W., and Metz, D.B. Selective distribution of blood through the terminal vascular bed of mesenteric structures and skeletal muscle. Angiology 6, 282, 1955.
109. Worthen, D.M., Fenton, B.M., Rosen, P., and Zweifach, B. Morphometry of diabetic conjunctival blood vessels. Ophthalmology 88, 655, 1981.
110. Skalak, T.C., and Schmid-Schonbein, G.W. The microvasculature in skeletal muscle. IV. A model of the capillary network. Microvasc. Res. 32, 333, 1986.
111. Gazit, Y., Baish, J.W., Safabakhsh, N., Leunig, M., Baxter, L.T., and Jain, R.K. Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 4, 395, 1997.
112. Less, J.R., Skalak, T.C., Sevick, E.M., and Jain, R.K. Microvascular architecture in mammary carcinoma: Branching patterns and vessel dimensions. Cancer Res. 51, 265, 1991.
113. Schmid-Schonbein, G.W., Skalak, T.C., and Firestone, G. The microvasculature in skeletal muscle. V. The microvascular arcades in normotensive and hypertensive rats. Microvasc. Res. 34, 385, 1987.
114. Skalak, T.C., and Price, R.J. The role of mechanical stress in microvascular remodeling. Microcirculation 3, 143, 1996.
115. Van Gieson, E.J., Murfee, W.L., Skalak, T.C., and Price, R.J. Enhanced smooth muscle coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ. Res. 92, 929, 2003.
116. Zeller, P.J., Skalak, T.C., Ponce, A.M., and Price, R.J. In vivo chemotactic properties and spatial expression of PDGF in developing mesenteric microvessel networks. Am. J. Physiol. Heart Circ. Pysiol. 280, H2116, 2001.
117. Brey, E.M., King, T.W., Johnston, C., McIntire, L.V., Reece, G.R., and Patrick, C.W., Jr. A technique for quantitative three-dimensional analysis of microvascular structure. Microvasc. Res. 63, 279, 2002.
118. Brey, E.M., McIntire, L.V., Johnston, C.M., and Patrick, C.W., Jr. Three-dimensional, quantitative analysis of desmin and smooth muscle a actin expression during angiogenesis. Ann. Biomed. Eng. 32, 1100, 2004.
119. Bentley, M.D., Ortiz, M.C., Ritman, E.L., and Romero, J.C. The use of microcomputed tomorgraphy to study microvasculature in small rodents. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1267, 2002.
120. Momose, A., Takeda, T., and Itai, Y. Blood vessels: Depiction at phase-contrast X-ray imaging without contrast agents in the mouse and rat-feasibility study. Radiology 217, 593, 2000.
121. Shi, D., Anastasio, M.M., De Carlo, F., and Pan, X. Half-scan and single-plane intensity diffraction tomography for phase objects. Phys. Med. Biol. 49, 2733, 2004.
122. Chang, Y.S., di Tomoso, E., McDonald, D.M., Jones, R., Jain, R.K., and Munn, L.L. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc. Natl. Acad. Sci. U.S.A. 97, 14608, 2000.
123. Hashizume, H., Baluk, P., Morikawa, S., McLean, J.W., Thurston, G., Roberg, S., Jain, R.K., and McDonald, D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363, 2000.
124. Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R.K., and McDonald, D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160, 985, 2000.
125. Folkman, J.H., and Haudenschild, C. Angiogenesis in vitro. Nature 288, 551, 1980.
126. Vailhe, B., and Feige, J.J. In vitro models of vasculogenesis and angiogenesis. Lab. Invest. 81, 439, 2001.
127. Davis, G.E., Bayless, K.J., and Mavila, A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Rec. 268, 252, 2002.
128. Nicosia, R.F., and Ottinetti, A. Growth of microvessels in serum-free matrix culture of rat aorta: A quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115, 1990.
129. Zhu, W.H., and Nicosia, R.F., The thin rat aortic assay: A modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 5, 81, 2002.
130. Brown, K.J., Mayer, S.F., Bezos, A., Maguire, D.J., Ford, M.D., and Parish, C.R. A novel in vitro angiogenesis assay. Lab. Invest. 75, 539, 1996.
131. Vernon, R.B., and Sage, E.H. A novel, quantitative model for study of endothelial cell migration and sprout formation within 3-dimensional collagen matrices. Microvasc. Res. 143, 1341, 1999.
132. Xue, L., and Greisler, H.P. Angiogenesis effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery 132, 259, 2002.
133. Korff, T., Kimmina, S., Martiny-Baron, G., and Augustin, H.G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 15, 447, 2001.
134. Donovan, D., Brown, N.J., Bishop, E.T., and Lewis, C.E. Comparison of three in vitro human angiogenesis assays with capillaries formed in vivo. Angiogenesis 4, 113, 2001.
135. Tong, S., and Yuan, F. Numerical simulations of angiogenesis in the cornea. Microvasc. Res. 61, 14, 2001.
136. Anderson, A.R., and Chaplain, M.A. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857, 1998.
137. Sun, S., Wheeler, M.F., Obeyesekere, M., and Patrick, C.W., Jr. A deterministic model of growth factor-induced angiogenesis. Bull. Math. Biol. 67, 313, 2004.
138. Nekka, F., Kyriacos, S., Kerrigan, C., and Cartilier, L. A model of growing vascular structures. Bull. Math. Biol. 58, 409, 1996.
139. Baish, J.W., Gazit, Y., Berk, D.A., Nozue, M., Baxter, L.T., and Jain, R.K. Role of tumor vasculature in nutrient and drug delivery: An invasion percolation-based network model. Microvasc. Res. 51, 327, 1996.
140. Peirce, S.M., Van Gieson, E.J., and Skalak, T.C. Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J. 18, 731, 2004.
141. Arakelyan, L., Vainstein, V., and Agur, Z. A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of antiangiogenic and anti-maturation therapy on vascular tumor growth. Angiogenesis 5, 203, 2002.
142. Zakrzewicz, A., Secomb, T.W., and Pries, A.R. Angioadaptation keeping the vascular system in shape. News Physiol. Sci. 17, 197, 2002.